ahlam1399
03-06-2016, 04:14 AM
GSK asthma drug Nucala?s long-term study supports safety profile
(Reuters) - GlaxoSmithKline Plc said on Saturday its asthma drug, Nucala, which is already approved in the United States and Europe, showed a similar safety profile in a long-term study compared with previous studies.
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2.img (http://da.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/ach.img (http://adchoice.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/ach.htm)http://pi.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2t.imghttp://pi2.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e0e6c3d/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DeDMqz7pVsc:rhfdMZPtsEk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DeDMqz7pVsc:rhfdMZPtsEk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DeDMqz7pVsc
(Reuters) - GlaxoSmithKline Plc said on Saturday its asthma drug, Nucala, which is already approved in the United States and Europe, showed a similar safety profile in a long-term study compared with previous studies.
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2.img (http://da.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/ach.img (http://adchoice.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/ach.htm)http://pi.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2t.imghttp://pi2.feedsportal.com/r/247393789101/u/49/f/654207/c/35217/s/4e0e6c3d/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4e0e6c3d/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DeDMqz7pVsc:rhfdMZPtsEk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DeDMqz7pVsc:rhfdMZPtsEk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DeDMqz7pVsc:rhfdMZPtsEk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DeDMqz7pVsc